Tremendous Growth Forecasted for mHealth Market: P&S Intelligence

New York, New York, UNITED STATES

NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- The global mHealth market is being driven by the increasing penetration of tablets and smartphones, and growing adoption of connected healthcare devices and mHealth apps. Rising geriatric population prone to chronic diseases, increasing focus on patent-centric healthcare, and growing demand for remote patient monitoring are also helping in this regard. Generating a revenue of $23.0 billion in 2017 as per a P&S Intelligence study, the market is predicted to advance through the forecast period 2018–2023 at a CAGR of 33.5%!

Request to get the sample pages of the report:

mHealth refers to the collection of medical data and delivery of healthcare services via mobile phones and tablets. On the basis of offering, the mHealth market can be divided into mHealth apps, connected devices, and services. Among these, the connected devices category led the market in 2017 with 57.2% share, due to a growing demand for remote patient monitoring solutions. In places, where people’s houses and healthcare centers are distant, these collect patients’ medical data and send it to medical practitioners via the internet, thus allowing for real-time disease management and improved patient outcomes.

Among the several types of connected devices available are blood pressure monitors, blood glucose monitors, multiparameter monitors, echocardiography (ECG) monitors, sleep apnea monitors, pulse oximeters, and others. In 2017, blood pressure monitors held the largest revenue share (28.7%) in the mHealth market owing to an increased prevalence of chronic disease and the easy mobility of such devices. While blood pressure monitors will still be the market leader during the forecast period, blood glucose monitors will witness the highest CAGR (31.9%) due to the increasing number of diabetes patients.

Browse report overview with 186 tables and 34 figures spread through 203 pages and detailed TOC on “mHealth Market” at:

Thus, we see that chronic diseases will be one of the major growth factors of the mHealth market in the future. As per a Centers for Disease Control and Prevention report, dated July 2017, 30.3 million people in the U.S. already had diabetes, while 84.1 million more were suffering from prediabetes, which can lead to type 2 diabetes, if not treated. Other common chronic diseases include cardiovascular diseases, stroke, chronic obstructive pulmonary disease, and cancer. With mHealth apps, doctors can help patients manage these diseases via remote monitoring and e-consultation.

Further, by monitoring patients’ condition, such apps also help in medical adherence, which is crucial to managing chronic issues. This feature, coupled with their easy availability and cost-effectiveness, is increasing their demand in high-income countries as well as low and middle-income countries. This gives mHealth market players a lucrative growth potential, as they could benefit by launching advanced chronic disease management apps. This is supported by the study finding that during the forecast period, mHealth apps category within the offering segment will advance with the greatest CAGR (38.9%).

Make enquiry before buying the report:

By recording and sharing medical data, connected devices and mHealth apps also lower the healthcare expenditure by minimizing hospital readmissions, clinic revisits, medical tests, and other physical examinations. A study, conducted by New York University, Harbin Institute of Technology and Carnegie Mellon University between 2015 and 2016, showed that mHealth helped reduce the glycated hemoglobin and blood glucose levels, hospital visits, and medical expenses of type 2 diabetes patients.

Therefore, it is clear that the growing prevalence of chronic diseases and the need to reduce healthcare costs will take the domain forward.

More Related Reports by P&S Intelligence

Blockchain in Healthcare Market

Geographically, Asia-Pacific (APAC) is anticipated to be the fastest growing blockchain in healthcare market, with at a CAGR of over 70.0% during the forecast period. This fastest growth is primarily attributed to the growing focus on blockchain technology in this region as well as unmet need in areas of clinical data exchange and interoperability, and drug supply chain management. For example, in July 2018, Singapore Innovate Pte. Ltd. (SGInnovate), Singapore’s government-owned technology development firm, invested in MediLOT Technologies, a blockchain and healthcare analytics start-up.

Electronic Health Record Market

The electronic health record market is forecasted to witness the fastest growth in Asia-Pacific (APAC), at a CAGR of 5.7%. This growth is attributed to the aggressive investments by governments, non-profit entities, and the private sector in EHR systems; growing aging population; and rising incidence of chronic diseases in various countries, such as India and China.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.


P&S Intelligence

Toll-free: +1-888-778-7886 (USA/Canada)

International: +1-347-960-6455



Connect with us: LinkedIn | Twitter | Facebook